Protection against developmental retarda
โ
Gozes, Illana ;Bachar, Michal ;Bardea, Amos ;Davidson, Ariane ;Rubinraut, Sarah
๐
Article
๐
1997
๐
John Wiley and Sons
๐
English
โ 152 KB
๐ 2 views
Stearyl-Nle 17 -VIP (SNV) is a novel milestones, with peptide-treated animals developing agonist of vasoactive intestinal peptide (VIP) exhibas fast as control animals and exhibiting improved iting a 100-fold greater potency than the parent molecule and specificity for a receptor associated with neu